Dr. Jen Streeter and her team at the University of Iowa are pioneering the Iowa Living Human Heart Research Program and developing Radiopaque Aptamer Dimers (RADs), innovative contrast agents designed to improve cardiac imaging while reducing kidney risks, exemplifying how clinician insight and cross-campus collaboration can drive transformative healthcare solutions.

A new tool to help patients with chronic lung diseases, being studied at the University of Iowa (UI) College of Engineering, has received a $2.55 million in funding from the National Institutes of Health Small Business Innovation Research (SBIR) program.

Arrhythmia specialists at University of Iowa Health Care Heart and Vascular Center recently performed their 800th procedure using the Farapulse™ pulsed field ablation system — a new, advanced treatment for atrial fibrillation (Afib).

12 graduate trainees have been selected from a competitive pool of outstanding applicants to participate in the Iowa Innovation Leadership Fellows Program, a year-long educational experience designed to immerse them in the dynamic world of healthcare innovation.

Siddhanth Hejmady’s journey into pharmaceutical sciences started back in Mumbai, where his passion for chemistry and biology led him to pursue pharmacy in undergrad. He describes it as the perfect intersection of both fields: how drugs are made, formulated, and ultimately used to help people.

If you’re unsure of your career path but interested in science, medicine, or making a difference, biomanufacturing might be the field you didn’t know you were looking for. Just ask Dr. James Byrne, Assistant Professor of Radiation Oncology and Biomedical Engineering at the University of Iowa, who combines patient care with lab research to bridge the gap between science and real-world impact.

Ashley Cooney, Ph.D., didn’t just attend the University of Iowa — she built her entire academic and professional life here. From undergraduate student to postdoctoral scholar, and now a faculty member and 2024–2025 Iowa Innovation Leadership Fellow, Cooney’s journey proves that sometimes staying in one place can lead to remarkable growth.

BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia (VT) treatment market

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation

A little-known, not-taught facet of the nursing profession is the art of the workaround – taking something that isn’t working in the situation and making it fit for whatever the patient or fellow staff members need.